drug · small molecule
quemliclustat
Phase 3updated 3mo agoby $RCUS Arcus Biosciences, Inc.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying quemliclustat
- phase2A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
- phase3Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- phase1Metabolism, Excretion, and Mass Balance Study of Quemliclustat in Healthy Adult Participants (ARC-24)
- phase2Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
- phase2Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
- phase2Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
- phase2Study With Various Immunotherapy Treatments in Participants With Lung Cancer
- phase2Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 19m ago
Found something off?
comments(0)
5-min edit window · permanent after that